Routine quarterly RTA certificate for securities dematerialization Q2 FY26
BIOFILCHEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.9 pts more than Nifty Microcap 250 and 2.0 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Biofil Chemicals and Pharmaceuticals has submitted a routine compliance certificate under SEBI Regulation 74(5) for the quarter ended 30 September 2026. The certificate, issued by the company's Registrar and Share Transfer Agent Ankit Consultancy Private Limited, confirms that all share certificates received for dematerialization during the quarter were processed, confirmed to the depositories, and the old physical certificates were cancelled within 15 days. The names of depositories have been substituted as registered owners in the company's member register. This is a standard quarterly procedural filing required from listed companies.
No material impact on shareholders or stock price. This is a routine regulatory housekeeping filing confirming proper processing of demat requests.